ETF Holdings Breakdown of ACCD

Stock NameAccolade Inc
TickerACCD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS00437E1029
LEI549300PHKG8J7A22NF08

News associated with ACCD

Barclays PLC Has $519,000 Position in Accolade, Inc. (NASDAQ:ACCD)
Barclays PLC lifted its holdings in shares of Accolade, Inc. (NASDAQ:ACCD – Free Report) by 8.3% during the fourth quarter, HoldingsChannel reports. The firm owned 151,493 shares of the company’s stock after acquiring an additional 11,592 shares during the quarter. Barclays PLC’s holdings in Accolade were worth $519,000 as of its most recent SEC filing. […] - 2025-05-09 07:32:50
Stifel Financial Corp Grows Stock Holdings in Accolade, Inc. (NASDAQ:ACCD)
Stifel Financial Corp lifted its stake in shares of Accolade, Inc. (NASDAQ:ACCD – Free Report) by 13.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 377,221 shares of the company’s stock after acquiring an additional 45,095 shares during the quarter. Stifel Financial […] - 2025-05-08 09:06:53
Renaissance Technologies LLC Decreases Position in Accolade, Inc. (NASDAQ:ACCD)
Renaissance Technologies LLC reduced its position in shares of Accolade, Inc. (NASDAQ:ACCD – Free Report) by 34.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 305,836 shares of the company’s stock after selling 163,764 shares during the period. Renaissance Technologies […] - 2025-05-01 07:58:54
Accolade, Inc. (NASDAQ:ACCD) Given Consensus Recommendation of “Hold” by Brokerages
Accolade, Inc. (NASDAQ:ACCD – Get Free Report) has been given a consensus rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Thirteen investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among analysts that […] - 2025-04-30 06:08:53
Intech Investment Management LLC Grows Position in Accolade, Inc. (NASDAQ:ACCD)
Intech Investment Management LLC increased its position in Accolade, Inc. (NASDAQ:ACCD – Free Report) by 48.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,984 shares of the company’s stock after purchasing an additional 12,124 shares during the period. […] - 2025-03-28 07:56:54
Accolade, Inc. (NASDAQ:ACCD) Short Interest Update
Accolade, Inc. (NASDAQ:ACCD – Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 1,560,000 shares, a decrease of 22.0% from the February 13th total of 2,000,000 shares. Approximately 2.1% of the company’s shares are sold short. Based […] - 2025-03-18 07:14:55
Analyzing Accolade (NASDAQ:ACCD) and eBay (NASDAQ:EBAY)
eBay (NASDAQ:EBAY – Get Free Report) and Accolade (NASDAQ:ACCD – Get Free Report) are both retail/wholesale companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership. Analyst Recommendations This is a breakdown of recent ratings and […] - 2025-02-17 09:35:01

ACCD institutional holdings

The following institutional investment holdings of ACCD have been identified

Date ETF ISIN/Name Num Shares Book value
2025-04-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 96,393USD 676,679
Total =96,393 USD 676,679
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.